Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay
Potency assessment of monoclonal antibodies or corresponding biosimilars in cell-based assays is an essential prerequisite in biopharmaceutical research and development. However, cellular bioassays are still subject to limitations in sample throughput, speed, and often need costly reagents or labels...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
[13 September 2024]
|
| In: |
Scientific reports
Year: 2024, Jahrgang: 14, Pages: 21462-1-21462-11 |
| ISSN: | 2045-2322 |
| DOI: | 10.1038/s41598-024-71483-3 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41598-024-71483-3 Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41598-024-71483-3 
|
| Verfasserangaben: | Stefan Schmidt, Alexander Geisel, Thomas Enzlein, Björn C. Fröhlich, Louise Pritchett, Melanie Verneret, Christian Graf & Carsten Hopf |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1925237788 | ||
| 003 | DE-627 | ||
| 005 | 20260212150747.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250509s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41598-024-71483-3 |2 doi | |
| 035 | |a (DE-627)1925237788 | ||
| 035 | |a (DE-599)KXP1925237788 | ||
| 035 | |a (OCoLC)1528045095 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schmidt, Stefan |e VerfasserIn |0 (DE-588)138987768X |0 (DE-627)1960926276 |4 aut | |
| 245 | 1 | 0 | |a Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay |c Stefan Schmidt, Alexander Geisel, Thomas Enzlein, Björn C. Fröhlich, Louise Pritchett, Melanie Verneret, Christian Graf & Carsten Hopf |
| 264 | 1 | |c [13 September 2024] | |
| 300 | |b Diagramme, Illustrationen | ||
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.05.2025 | ||
| 520 | |a Potency assessment of monoclonal antibodies or corresponding biosimilars in cell-based assays is an essential prerequisite in biopharmaceutical research and development. However, cellular bioassays are still subject to limitations in sample throughput, speed, and often need costly reagents or labels as they are based on an indirect readout by luminescence or fluorescence. In contrast, whole-cell Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) Mass Spectrometry (MS) has emerged as a direct, fast and label-free technology for functional drug screening being able to unravel the molecular complexity of cellular response to pharmaceutical reagents. However, this approach has not yet been used for cellular testing of biologicals. In this study, we have conceived, developed and benchmarked a label-free MALDI-MS based cell bioassay workflow for the functional assessment of complement-dependent cytotoxicity (CDC) of Rituximab antibody. By computational evaluation of response profiles followed by subsequent m/z feature annotation via fragmentation analysis and trapped ion mobility MS, we identified adenosine triphosphate and glutathione as readily MS-assessable metabolite markers for CDC and demonstrate that robust concentration-response characteristics can be obtained by MALDI-TOF MS. Statistical assay performance indicators suggest that whole-cell MALDI-TOF MS could complement the toolbox for functional cellular testing of biopharmaceuticals. | ||
| 650 | 4 | |a Biologics | |
| 650 | 4 | |a Biomarkers | |
| 650 | 4 | |a Drug screening | |
| 650 | 4 | |a Pharmacology | |
| 700 | 1 | |a Geisel, Alexander |e VerfasserIn |4 aut | |
| 700 | 1 | |a Enzlein, Thomas |e VerfasserIn |0 (DE-588)1353427064 |0 (DE-627)1914650964 |4 aut | |
| 700 | 1 | |a Fröhlich, Björn C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pritchett, Louise |e VerfasserIn |4 aut | |
| 700 | 1 | |a Verneret, Melanie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Graf, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hopf, Carsten |d 1967- |e VerfasserIn |0 (DE-588)120834588 |0 (DE-627)705023869 |0 (DE-576)180073133 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Scientific reports |d [London] : Springer Nature, 2011 |g 14(2024), Artikel-ID 21462, Seite 21462-1-21462-11 |h Online-Ressource |w (DE-627)663366712 |w (DE-600)2615211-3 |w (DE-576)346641179 |x 2045-2322 |7 nnas |a Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay |
| 773 | 1 | 8 | |g volume:14 |g year:2024 |g elocationid:21462 |g pages:21462-1-21462-11 |g extent:11 |a Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41598-024-71483-3 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41598-024-71483-3 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20250509 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 120834588 |a Hopf, Carsten |m 120834588:Hopf, Carsten |d 910000 |d 950000 |d 950950 |e 910000PH120834588 |e 950000PH120834588 |e 950950PH120834588 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950950/ |p 8 |y j | ||
| 999 | |a KXP-PPN1925237788 |e 4723051945 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Stefan Schmidt, Alexander Geisel, Thomas Enzlein, Björn C. Fröhlich, Louise Pritchett, Melanie Verneret, Christian Graf & Carsten Hopf"]},"note":["Gesehen am 09.05.2025"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay","title_sort":"Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay"}],"relHost":[{"recId":"663366712","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["2045-2322"],"eki":["663366712"],"zdb":["2615211-3"]},"language":["eng"],"origin":[{"dateIssuedDisp":"2011-","publisher":"Springer Nature ; Nature Publishing Group","publisherPlace":"[London] ; London","dateIssuedKey":"2011"}],"title":[{"title_sort":"Scientific reports","title":"Scientific reports"}],"disp":"Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassayScientific reports","part":{"extent":"11","text":"14(2024), Artikel-ID 21462, Seite 21462-1-21462-11","volume":"14","pages":"21462-1-21462-11","year":"2024"},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 12.07.24"],"pubHistory":["1, article number 1 (2011)-"]}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"[13 September 2024]"}],"person":[{"family":"Schmidt","display":"Schmidt, Stefan","given":"Stefan","role":"aut"},{"role":"aut","given":"Alexander","display":"Geisel, Alexander","family":"Geisel"},{"family":"Enzlein","given":"Thomas","display":"Enzlein, Thomas","role":"aut"},{"role":"aut","display":"Fröhlich, Björn C.","given":"Björn C.","family":"Fröhlich"},{"display":"Pritchett, Louise","given":"Louise","role":"aut","family":"Pritchett"},{"family":"Verneret","given":"Melanie","display":"Verneret, Melanie","role":"aut"},{"family":"Graf","role":"aut","display":"Graf, Christian","given":"Christian"},{"family":"Hopf","role":"aut","display":"Hopf, Carsten","given":"Carsten"}],"physDesc":[{"extent":"11 S.","noteIll":"Diagramme, Illustrationen"}],"id":{"eki":["1925237788"],"doi":["10.1038/s41598-024-71483-3"]},"language":["eng"],"recId":"1925237788"} | ||
| SRT | |a SCHMIDTSTELABELFREEA1320 | ||